To explore the underlying mechanisms of responsiveness to anti-PD-1 therapy in ESCC, we compared T-cell proportions between the PPCT-N and PPCT-P groups, using the nCRT-P group as a control. Here, PDCD1 is linked to esophageal squamous cell carcinoma.